42 /100
MEDIUM RISK
Score updated May 30, 2026

BCAX — Bicara Therapeutics Inc. Dilution Risk Tracker

Track BCAX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BCAX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
50
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for BCAX.
🔔 Track BCAX — Get forecast alerts →

💹 Market Data

Market Cap$1.43B
Shares Outstanding65.70M
Float36.63M
Cash$539.75M
Debt$1.44M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 15.1% shares (2025Q4 vs prior)
140 institutional holders · 58.15M shares
#1 RA CAPITAL MANAGEMENT, L.P. 6.96M shares
#2 Siren, L.L.C. 5.22M shares
#3 Vestal Point Capital, LP 3.58M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest9.85M
Days to Cover17.3
% of Float26.9%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2024
4 INSIDER TRANSACTION Mar 26, 2026
4 INSIDER TRANSACTION Mar 24, 2026
4 INSIDER TRANSACTION Mar 17, 2026
4 INSIDER TRANSACTION Mar 11, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track BCAX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BCAX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for BCAX
📊 BCAX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 BCAX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.